Meag Munich Ergo’s HCA Healthcare HCA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$2.98M Buy
7,768
+246
+3% +$88.6K 0.08% 118
2025
Q1
$2.6M Buy
+7,522
New +$2.42M 0.08% 109
2024
Q3
Sell
-1,634
Closed -$525K 202
2024
Q2
$525K Sell
1,634
-6,056
-79% -$1.97M 0.02% 136
2024
Q1
$2.56M Buy
7,690
+7,391
+2,472% +$2.26M 0.09% 105
2023
Q4
$80.9K Sell
299
-177
-37% -$43.7K ﹤0.01% 170
2023
Q3
$117K Buy
+476
New +$130K 0.01% 153
2023
Q2
Sell
-412
Closed -$109K 188
2023
Q1
$109K Sell
412
-2,360
-85% -$599K 0.01% 168
2022
Q4
$665K Sell
2,772
-3,050
-52% -$683K 0.04% 168
2022
Q3
$1.07M Sell
5,822
-8,357
-59% -$1.66M 0.07% 132
2022
Q2
$2.38M Sell
14,179
-529
-4% -$114K 0.14% 97
2022
Q1
$3.73M Sell
14,708
-3,459
-19% -$869K 0.27% 74
2021
Q4
$4.71M Buy
+18,167
New +$4.45M 0.33% 70
2021
Q3
Sell
-7,508
Closed -$1.55M 264
2021
Q2
$1.55M Sell
7,508
-251
-3% -$51.2K 0.15% 145
2021
Q1
$1.46M Buy
+7,759
New +$1.37M 0.15% 144
2020
Q4
Sell
-7,211
Closed -$899K 204
2020
Q3
$899K Hold
7,211
0.17% 136
2020
Q2
$700K Sell
7,211
-2,146
-23% -$223K 0.13% 144
2020
Q1
$841K Sell
9,357
-4,111
-31% -$532K 0.2% 103
2019
Q4
$1.99M Buy
13,468
+1,065
+9% +$143K 0.21% 117
2019
Q3
$1.47M Buy
12,403
+2,089
+20% +$270K 0.08% 279
2019
Q2
$1.39M Hold
10,314
0.11% 206
2019
Q1
$1.33M Buy
+10,314
New +$1.39M 0.11% 203
2018
Q4
Sell
-25,781
Closed -$3.55M 367
2018
Q3
$3.55M Buy
25,781
+7,901
+44% +$984K 0.21% 141
2018
Q2
$1.86M Sell
17,880
-3,652
-17% -$369K 0.12% 219
2018
Q1
$2.08M Buy
21,532
+7,691
+56% +$746K 0.09% 268
2017
Q4
$1.23M Buy
+13,841
New +$1.11M 0.05% 336
2017
Q2
Sell
-73,671
Closed -$6.55M 314
2017
Q1
$6.55M Buy
73,671
+36,461
+98% +$3.04M 0.26% 145
2016
Q4
$2.77M Buy
+37,210
New +$2.79M 0.13% 189
2016
Q3
Sell
-41,186
Closed -$3.17M 269
2016
Q2
$3.17M Hold
41,186
0.29% 100
2016
Q1
$3.21M Buy
+41,186
New +$2.88M 0.17% 148

Other funds holding HCA

Meag Munich Ergo's HCA Position: Q2 2025 in Review

Meag Munich Ergo increased its HCA Healthcare (HCA) stake by 3.3% in Q2 2025, buying an estimated $88.6K and bringing the position to 7,768 shares worth $2.98M. The position accounts for 0.08% of the portfolio, ranked #118.

Meag Munich Ergo first reported a position in HCA in Q1 2016 and has held it in 29 quarters since. The position peaked at $6.55M in Q1 2017. 1,248 funds tracked by Wall St. Rank hold HCA as of Q2 2025.

  • Meag Munich Ergo held 7,768 shares of HCA Healthcare worth $2.98M as of Q2 2025.
  • Meag Munich Ergo bought 246 HCA Healthcare shares in Q2 2025, an estimated $88.6K.
  • HCA Healthcare made up 0.08% of Meag Munich Ergo's portfolio in Q2 2025, its #118 holding.
  • Meag Munich Ergo first reported a position in HCA Healthcare in Q1 2016 and has held it in 29 quarters since.
  • Meag Munich Ergo's HCA Healthcare position peaked at $6.55M in Q1 2017.
  • 1,248 funds tracked by Wall St. Rank held HCA Healthcare as of Q2 2025.

Based on Meag Munich Ergo's 13F filing for Q2 2025, filed 16 Jul 2025.